PHARMADVICE ApS: Financial statements 2023
CVR: 26527651
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMADVICE ApS (CVR 26527651) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 5,940,070 and a net result of DKK 608,525 compared with DKK 717,002 the year before. That is an increase of 11.8% compared with the year before. Equity in the 2023 report amounted to DKK 1,439,821. The solvency ratio was 64.2%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 5,940,070
- Profit/Loss
- DKK 608,525
- Equity
- DKK 1,439,821
- Total Assets
- DKK 2,241,763
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 5.9 mio. | 609 t. | 1.4 mio. | 6 |
| 2022 | - | 5.3 mio. | 717 t. | 1.5 mio. | 6 |
| 2021 | - | 3.9 mio. | 276 t. | 839 t. | 5 |
| 2020 | - | 4.2 mio. | 309 t. | 1 mio. | 5 |
| 2019 | - | 4.6 mio. | -28 t. | 704 t. | 7 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMADVICE ApS has published its annual report for 2022. Gross profit came to DKK 5,311,830, and the net result was DKK 717,002.
About PHARMADVICE ApS
PHARMADVICE ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2002. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Susanne Ølsgaard Felumb. The company is owned by Felumb Holding ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 6,375,693 and a net result of DKK 503,512 compared with DKK 658,935 the year before. Equity in the 2025 report amounted to DKK 1,402,268.